No Data
SANKO ETC [Stocks with Interesting Characteristics Based on Volume Changes]
Stock closing prices compared to the previous day Volume *<2762>* SANKO 106,592,763.00 *<1867>* Ueki Group 187,415,418,400.00 *<4113>* Tago Chemicals Industry 119,913,826,430.00 *<4053>* Sun Asterisk 570,371,105.00 *<5631>* Nisshin Steel Works 615,984,340,183.00 *<6428>* Oizumi 322,146,300.
Stocks that moved or were traded in the first half of the session.
*Japan Steel Works <5631> 6065 +749 Buying in defense-related stocks in response to reports of increased USA defense budget targets. *Okuma <6103> 3685 +390 Stimulated by the surge in DMG Mori Seiki as a European Index-related Machinery stock. *Makita <6586> 5352 +550 European Index-related stocks are generally high due to the DAX rise and Euro strengthening. *Symphony Technology <6507> 6880 +640 SMBC Nikko Securities has raised the Target Price.
Stock News Premium = Selecting strong stocks from the October to December financial results - 3
＜Tamaoka Chemicals, Recovery of Monomers for Smart Phones＞ Tamaoka Chemical Industry <4113.T> is seeing a recovery in demand for monomers used in smartphone lenses, which has long struggled. Following the Earnings Reports for the third quarter of the fiscal year ended March (October-December of last year), the stock price surged, but considering the previous adjustments, there is still significant room for reevaluation. The company engages in electronic materials, medical and Agrochemical intermediates, and functional raw materials. The optical Resin polymer used for small camera lens materials is among its main products. Smart Phone
＜Individual Stock Trends＞ DM Mitsui Sugar, Taoka Chemical, Chudenko, JCR Pharma, JTEKT = After the 3rd session.
DM Mitsui Sugar <2109.T> - raised the consolidated profit Financial Estimates for the fiscal year ending March 2025. Taoka <4113.T> - upwardly revised the consolidated profit Financial Estimates for the fiscal year ending March 2025 and increased the year-end Dividends estimate from the previous 12 yen to 18 yen (previous year's actual 9 yen). Chudenko <1941.T> - upwardly revised the consolidated performance Financial Estimates for the fiscal year ending March 2025. JCR Pharma <4552.T> - downgraded the consolidated performance Financial Estimates for the fiscal year ending March 2025. JTEKT <6473.T> - downwardly revised the consolidated net profit Financial Estimates (IFRS) for the fiscal year ending March 2025.
Taoka Chemical Revises Financial and Dividend Forecasts for Fiscal Year 2025
Taoka Chemical Reports Strong Q3 2024 Financial Results
